Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
SYNformulas GmbH logo — A Global Leader in Probiotics

SYNformulas GmbH

A Global Leader in Probiotics

Founded 2011 Germany Grafelfing, Germany 34 employees Biopharma, Health Care +1

General Information

Company Name SYNformulas GmbH
Founded Year 2011
Location Germany Grafelfing, Germany
Employees 34
Industries Biopharma, Health Care, Pharmaceutical
Hiring 41 roles posted in the month to 26 Sep 2026
Social

BounceWatch is an independent company data service, not affiliated with SYNformulas GmbH. To contact SYNformulas GmbH, visit synformulas.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Actively Hiring Sep 23, 2026

Hiring for 41 positions in the last 30 days.

Key Role Hiring Sep 21, 2026

Hiring for key role: CEO.

Get alerts when SYNformulas GmbH shows new signals

About SYNformulas GmbH

SYNformulas GmbH is a global leader in the probiotics industry, focusing on researching intelligent bacteria for the therapy of patients with allergies and gastrointestinal diseases. Under the brand name Kijimea®, the company develops and distributes medical products, dietary supplements, and products for supplementary balanced diets. The company achieved a breakthrough in the treatment of irritable bowel diseases, with the patented bacteria strain MIMBb75 showing significant efficacy in two independent studies for irritable bowel syndrome. Recently, it was included in the updated S3 guideline for irritable bowel syndrome, the standard guideline for clinical practice. The company, founded in 2011 and headquartered in Germany, is focused on pioneering product development with clinically proven efficacy, relying on a knowledgeable research and development team, as well as collaboration with a wide network of internationally recognized researchers and universities. The company has not disclosed its last investment or the investors involved. SYNformulas GmbH operates within the Biopharma, Health Care, and Pharmaceutical industries.

Taxonomy: Probiotics, Therapy, Gut Health, Microbiome Research, Medical Products, Supplements, Digestive Disorders, Allergies, Innovative Therapies, Research & Development, Postbiotics, OTC (Over the Counter), Clinical Studies

No funding data available for SYNformulas GmbH yet.

SYNformulas GmbH Alternatives & Competitors

SYNformulas GmbH vs
Aspen - SSA
Aspen - SSA Kenya

Aspen Pharma Group

111 employees
Health Care, Manufacturing
SYNformulas GmbH vs
MAXWELLIA
MAXWELLIA United Kingdom

Widening access to medicines

10 employees
Biopharma, Health Care
SYNformulas GmbH vs
Gulfcoast Clinical Research Center
Gulfcoast Clinical Research Center United States

Better Days Ahead

8 employees
Health Care, Health and Wellness

FAQ About SYNformulas GmbH

A Global Leader in Probiotics
SYNformulas GmbH was founded in 2011.
SYNformulas GmbH is headquartered in Grafelfing, Germany.
SYNformulas GmbH operates in Biopharma, Health Care and Pharmaceutical. Its work centres on Probiotics, Therapy, Gut Health and Microbiome Research.
SYNformulas GmbH has approximately 34 employees.
Top alternatives and competitors to SYNformulas GmbH include Aspen - SSA , MAXWELLIA, Gulfcoast Clinical Research Center, EternaTear, BIOTON S.A.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SYNformulas GmbH and Aspen - SSA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SYNformulas GmbH, https://bouncewatch.com/company/synformulas-gmbh, updated 5 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes